Adelaide, SA

South Australian Health and Medical Research Institute

Mental Disorders

Post-Traumatic Stress Disorders

Panic Disorder

Verapamil

Vancomycin

Telmisartan

HB-1

Neomycin

HB BioTech, LLC

University of Adelaide

condition

allSponsorName

gender

Male

Female

overallStatus

Recruiting

Not yet recruiting

Active, not recruiting

Enrolling by invitation

Completed

Terminated

Withdrawn

Suspended

Unknown

type

Interventional

Observational

Expanded Access

phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Not Applicable

funderTypes

Industry

Other U.S. Federal agency

All others

ageGroup

Child (birth-17)

Adult (18-64)

Older Adult (65+)

The purpose of this study is to determine the safety and efficacy of HB-1, versus placebo in male and female adult patients aged 18 to 65 years, inclusive, with Post-Traumatic Stress Disorder (PTSD).

Safety and Efficacy of HB-1 for Post-Traumatic Stress Disorder

South Australian Health and Medical Research Institute | Adelaide, SA

Site insights

Work at this site?

Active trials

Safety and Efficacy of HB-1 for Post-Traumatic Stress Disorder

Trial sponsors